Performance comparison of the miDiagnostics COVID-19 PCR Test with the GeneXpert SARS-CoV-2, Seegene Allplex Sars-CoV-2 and Aries Sars-CoV-2 assays

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

‘We compared the miDiagnostics COVID-19 PCR Test in an acute regional Hospital setting to the standard of care Covid-19 testing at the time: GeneXpert SARS-CoV-2, Seegene Allplex Sars-CoV-2 and Aries Sars-CoV-2 assays. Nasopharyngeal swabs were collected from 200 symptomatic and asymptomatic patients. A standard of care swab and a study swab were collected in a randomized fashion.
In this pooled analysis, 165 swabs were compared to Seegene, 28 to GeneXpert and 5 to Aries. On a total of 198 paired samples, the miDiagnostics test correctly classified 49 samples as positive and 127 samples as negative when compared to the standard of care method. This resulted in a sensitivity of 90.74% and a specificity of 88.19%. The miDiagnostics COVID-19 PCR Test is a viable diagnostic platform for very fast direct PCR diagnosis of Sars-CoV-2. Further studies are still needed to evaluate the performance in other settings and against other test platforms.’

Article activity feed